Point: Cervical cancer screening guidelines should consider observational data on screening efficacy in older women

American Journal of Epidemiology

Volumn 178, Issue 7, 2013, Pages 1020-1022

  Rustagi, Alison S ^a   Kamineni, Aruna ^b   Weiss, Noel S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

cervical cancer; health policy; Papanicolaou smear; screening; women's health

Indexed keywords

AGE CLASS; CANCER; DATA SET; ELDERLY POPULATION; GUIDELINE; HEALTH POLICY; PATHOLOGY; REPRODUCTIVE HEALTH; WOMENS HEALTH;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; GROUPS BY AGE; PAPANICOLAOU TEST; PRACTICE GUIDELINE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CERVICAL CANCER; HEALTH POLICY; PAPANICOLAOU SMEAR; SCREENING; WOMEN'S HEALTH;

AGE FACTORS; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

UNITED KINGDOM; UNITED STATES;

EID: 84884921418     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt167     Document Type: Article

References (19)

1. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-172.
2. Kulasingam S, Havrilesky L, Ghebre R, et al. Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. (AHRQ publication no. 11-05157-EF-1). Rockville, MD: Agency for Healthcare Research and Quality; 2011.
3. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003;89(1):88-93.
4. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ. 2009;339:b2968.
5. Andrae B, Kemetli L, Sparn P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100(9):622-629.
6. Kamineni A,Weinmann S, Shy K, et al. Cervical cancer screening efficacy in older women [published online ahead of print June 7, 2013]. Cancer Epidemiol Biomarkers Prev. (doi:10.1007/s10552-013-0239-4).
7. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ. 2012;344:e900.
8. IARCWorking Group on Cervical Cancer Screening. Screening for squamous cervical cancer-The duration of low risk following negative results in cervical cytology test: introduction. IARC Sci Publ. 1986(76):15-24.
9. Sawaya GF, Kerlikowske K, Lee NC, et al. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96(2):219-223.
10. Flannelly G, Monaghan J, Cruickshank M, et al. Cervical screening in women over the age of 50: results of a population-based multicentre study. BJOG. 2004;111(4): 362-368.
11. Meyer R, Lemay AL, Guy X, et al. Is there a benefit to continue Pap smear screening for cervical cancer after 65 years of age? A retrospective study on 53,644 women. Bull Cancer. 2012;99(4):409-415.
12. Rebolj M, van Ballegooijen M, Lynge E, et al. Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ. 2009;338: b1354.
13. van Oortmarssen GJ, Habbema JD. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer. 1991;64(3):559-565.
14. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425-434.
15. Morrison BJ, Coldman AJ, Boyes DA, et al. Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer. 1996;74(5):814-819.
16. Schiffman M, Glass AG, Wentzensen N, et al. A long-Term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1398-1409.
17. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119(11):2677-2684.
18. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 suppl):S5-S25, S25.e1- S25.e41.
19. Gonzlez P, Hildesheim A, Rodriguez AC, et al. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3044-3054.